MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB–NFIB fusion gene

Publisher： John Wiley & Sons Inc

E-ISSN： 1555-2039|244|2|143-150

ISSN： 0022-3417

Source： THE JOURNAL OF PATHOLOGY, Vol.244, Iss.2, 2018-02, pp. : 143-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Primary sinonasal adenoid cystic carcinoma presenting with skin metastases – genomic profile and expression of the MYB–NFIB fusion biomarker

By  

HISTOPATHOLOGY, Vol. 64, Iss. 3, 2014-02 ,pp. : 453-455

John Wiley & Sons Inc

Access to resources Recommend Favorite

MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma

By  

THE LARYNGOSCOPE, Vol. 125, Iss. 9, 2015-09 ,pp. : E292-E299

John Wiley & Sons Inc

Access to resources Recommend Favorite

MYB immunostaining is a useful ancillary test for distinguishing adenoid cystic carcinoma from pleomorphic adenoma in fine‐needle aspiration biopsy specimens

By  

CANCER CYTOPATHOLOGY, Vol. 122, Iss. 4, 2014-04 ,pp. : 257-265

John Wiley & Sons Inc

Access to resources Recommend Favorite

Male Breast Adenoid Cystic Carcinoma

By  

Case Reports in Oncology, Vol. 6, Iss. 3, 2013-10 ,pp. : 514-519

Karger

Access to resources Recommend Favorite

Genomic landscape of adenoid cystic carcinoma of the breast

By  

THE JOURNAL OF PATHOLOGY, Vol. 237, Iss. 2, 2015-10 ,pp. : 179-189

John Wiley & Sons Inc

Access to resources Recommend Favorite